Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFCG
4776
AFC Gamma
AFCG
$60.7M
| $1.66K | ﹤0.01% |
206
-6,943
| -97% | -$61.7K |
|
|
SRDX
4777
DELISTED
Surmodics
SRDX
| $1.64K | ﹤0.01% |
51
-4,093
| -99% | -$139K |
|
|
OPTN
4778
DELISTED
OptiNose
OPTN
| $1.64K | ﹤0.01% |
89
-2,945
| -97% | -$53K |
|
4779
Prelude Therapeutics
PRLD
$370M
| $1.63K | ﹤0.01% |
526
-3,315
| -86% | -$12.4K |
|
4780
Quad
QUAD
$434M
| $1.6K | ﹤0.01% |
319
-9,019
| -97% | -$47.3K |
|
4781
Orange County Bancorp
OBT
$521M
| $1.6K | ﹤0.01% |
74
-2,966
| -98% | -$64.8K |
|
4782
Astronics
ATRO
$3.37B
| $1.59K | ﹤0.01% |
120
-9,968
| -99% | -$150K |
|
|
UDMY
4783
DELISTED
Udemy
UDMY
| $1.54K | ﹤0.01% |
162
-27,043
| -99% | -$283K |
|
4784
PepGen
PEPG
$127M
| $1.53K | ﹤0.01% |
301
-43,147
| -99% | -$275K |
|
4785
Civeo
CVEO
$376M
| $1.51K | ﹤0.01% |
73
+66
| +943% | +$1.28K |
|
4786
CRA International
CRAI
$1.16B
| $1.51K | ﹤0.01% |
15
-3,280
| -100% | -$345K |
|
4787
Xometry
XMTR
$4.58B
| $1.51K | ﹤0.01% |
89
-10,992
| -99% | -$208K |
|
4788
Century Therapeutics
IPSC
$370M
| $1.51K | ﹤0.01% |
754
-7,585
| -91% | -$20.2K |
|
|
SGMO
4789
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.51K | ﹤0.01% |
2,514
-43,474
| -95% | -$46.5K |
|
|
OMGA
4790
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.5K | ﹤0.01% |
698
-49,211
| -99% | -$197K |
|
4791
Evolv Technologies
EVLV
$1.01B
| $1.49K | ﹤0.01% |
306
-35,330
| -99% | -$218K |
|
|
ZYXI
4792
DELISTED
Zynex
ZYXI
| $1.48K | ﹤0.01% |
185
-19,623
| -99% | -$164K |
|
4793
Capital Bancorp
CBNK
$615M
| $1.47K | ﹤0.01% |
77
-2,805
| -97% | -$54.4K |
|
|
CANF
4794
Can-Fite BioPharma American Depositary Shares
CANF
$6.77M
| $1.47K | ﹤0.01% |
28
| – | – |
|
4795
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$361M
| $1.46K | ﹤0.01% |
57
| – | – |
|
4796
Treace Medical Concepts
TMCI
$260M
| $1.46K | ﹤0.01% |
111
-14,357
| -99% | -$263K |
|
|
ASM
4797
Avino Silver & Gold Mines
ASM
$964M
| $1.45K | ﹤0.01% |
2,800
| – | – |
|
|
MTTR
4798
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.44K | ﹤0.01% |
664
-215,139
| -100% | -$603K |
|
4799
i3 Verticals
IIIV
$420M
| $1.44K | ﹤0.01% |
68
-7,225
| -99% | -$167K |
|
4800
Ranger Energy Services
RNGR
$345M
| $1.43K | ﹤0.01% |
101
-4,534
| -98% | -$52.9K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.